SwiftPharma
Karel Van De Woestijnestraat 6
9000 Gent
BE
SwiftPharma
Foundation date
04/02/2022
Sector
#Biotechnology - otherSubsector
- #Other - AgBio
- #Other - Cosmetics
- #Other - Environmental
- #Other - Industrial Biotechnology
- #Other - Nutraceuticals
Development of recombinant biologics using plants as mini-bioreactors. Our technology combines speed, agility, scalability, safety, and low-cost production completely animal-free
Upcoming events
All events-
1212 '23
BioFIT 2023
Event by: Eurasanté -
0602 '24
Discovery to Innovation in Animal Health - 2024
Event by: Ghent University, Provaxs, Paul Dick & Associates -
3011 '23
The GxP Academy: Aseptische Training en werken in LAF/Biosafety Cabinet
Event by: Advipro
News by SwiftPharma
More news-
SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars
Tuesday November 14th 2023
Read more
-
SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform
Monday October 9th 2023
Read more
-
SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.
Wednesday September 27th 2023
Read more
Jobs
More jobs-
-
-
27/11/23
Antwerp, Brussels, East Flanders, Hainaut, Liège, Limburg, Luxembourg, Namur, Flemish Brabant, Walloon Brabant, West Flanders, Remote
Project Manager Life Science & IVD
Permanent
Thema Group Belgium
More info?
Ellen Telleir
Communication Coordinator